Literature DB >> 6091186

Leukotriene B4, polymorphonuclear leukocytes and inflammatory exudates in the rat.

A W Ford-Hutchinson, G Brunet, P Savard, S Charleson.   

Abstract

Leukocyte numbers and Leukotriene B4- (LTB4-) and LTC4-immunoreactivity were measured in inflammatory exudates obtained from sponges impregnated with several irritants implanted subcutaneously in the rat. Sponges containing 1% uric acid, carrageenan or zymosan were implanted for 5h and compared to saline sponges. Increases in leukocyte numbers and LTB4-immunoreactivity were found in the presence of irritants, the highest concentrations being observed in the presence of zymosan. The presence of LTB4 was confirmed by liquid chromatographic (HPLC) analysis. A time course study was carried out with zymosan-impregnated sponges and the maximal rate of leukocyte infiltration was found to coincide with the maximal levels of LTB4-immunoreactivity. The LTC4-immunoreactivity was low and following analysis by HPLC was concluded to be unrelated to leukotrienes. The levels of LTB4-immunoreactivity, but not the numbers of leukocytes, were elevated compared to corresponding controls in sponges containing 0.01% ionophore A23187 (untreated rats) or in sponges containing zymosan (rats pretreated with indomethacin; 3 and 10 mg/kg p.o.). Impregnation of sponges with 3 X 10(-6)M LTB4 but not 3 X 10(-5) and 3 X 10(-7)M LTB4 induced a significant leukocyte migration. It was concluded that LTB4 can induce leukocyte migration into sponge exudates in the rat but that measurements of LTB4 in such exudates can not be correlated with the degree of leukocyte infiltration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091186     DOI: 10.1016/0090-6980(84)90110-2

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  13 in total

1.  The release of leukotriene B4 from human skin in response to substance P: evidence for the functional heterogeneity of human skin mast cells among individuals.

Authors:  T Okabe; M Hide; O Koro; N Nimi; S Yamamoto
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  The in vivo antiinflammatory effects of (E)-2,6-bis(1,1-dimethyl-ethyl)-4-[2-(5-methyl-1H-pyrazol-3-yl)ethenyl ] phenol (PD 127443) a novel dual inhibitor of 5-lipoxygenase and cyclooxygenase.

Authors:  D J Schrier; M A Adamchak; A M Boctor; C R Kostlan; D L Flynn; J H Jordan; M E Lesch; G C Okonkwo
Journal:  Agents Actions       Date:  1989-06

Review 3.  Leukotrienes in inflammation.

Authors:  M A Bray
Journal:  Agents Actions       Date:  1986-10

4.  Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut.

Authors:  E Kankuri; K Vaali; R Korpela; I Paakkari; H Vapaatalo; E Moilanen
Journal:  Inflammation       Date:  2001-10       Impact factor: 4.092

5.  Evaluation of chemokine- and phlogistin-mediated leukocyte chemotaxis using an in vivo sponge model.

Authors:  J S Fine; J V Jackson; A Rojas-Triana; L A Bober
Journal:  Inflammation       Date:  2000-08       Impact factor: 4.092

6.  Specific inhibition of leukotriene B4 (LTB4)-induced neutrophil emigration by 20-hydroxy LTB4: implications for the regulation of inflammatory responses.

Authors:  E R Pettipher; E D Salter; R Breslow; L Raycroft; H J Showell
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  Role of resident macrophages in canatoxin-induced in vivo neutrophil migration.

Authors:  C Barja-Fidalgo; C R Carlini; J A Guimarães; C A Flores; F Q Cunha; S H Ferreira
Journal:  Inflammation       Date:  1992-02       Impact factor: 4.092

8.  Effects of SC-41930 on leukocyte adherence and emigration in rat mesenteric venules.

Authors:  B J Zimmerman; T S Gaginella; D N Granger
Journal:  Agents Actions       Date:  1992-09

9.  The evolution of non-steroidal anti-inflammatory drugs and their mechanisms of action.

Authors:  J Vane
Journal:  Drugs       Date:  1987       Impact factor: 9.546

10.  Studies of eicosanoid production in the air pouch model of synovial inflammation.

Authors:  A D Sedgwick; P Lees
Journal:  Agents Actions       Date:  1986-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.